Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12;34(2):97-102.
doi: 10.1515/medgen-2022-2135. eCollection 2022 Jun.

Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism

Affiliations

Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism

Jelena Pozojevic et al. Med Genet. .

Abstract

X-linked dystonia-parkinsonism (XDP) is a neurodegenerative movement disorder that primarily affects adult Filipino men. It is caused by a founder retrotransposon insertion in TAF1 that contains a hexanucleotide repeat, the number of which differs among the patients and correlates with the age at disease onset (AAO) and other clinical parameters. A recent work has identified additional genetic modifiers of age-associated penetrance in XDP, bringing to light the DNA mismatch repair genes MSH3 and PMS2. Despite X-linked recessive inheritance, a minor subset of patients are female, manifesting the disease via various mechanisms such as homozygosity, imbalanced X-chromosome inactivation, or aneuploidy. Here, we summarize and discuss clinical and genetic aspects of XDP, with a focus on variable disease expressivity as a consequence of subtle genetic differences within a seemingly homogenous population of patients.

Keywords: X-linked dystonia-parkinsonism (XDP); age-related penetrance; genetic modifiers; repeat-length polymorphism; retrotransposon insertion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A Kaplan–Meier plot showing the increase in the age-related penetrance of XDP, i. e., a decrease in likelihood for men with the XDP haplotype to remain unaffected with increasing age.
Figure 2
Figure 2
A diagram showing the effect of the number of (CCCTCT)n repeats, alone, on age at onset (AAO) of XDP patients (white circles) and the combined effect of the harmful alleles and the number of repeats (red circle) and protective alleles and number of repeats (green circle). The latter two decrease the AAO by 7 years and increase the AAO by 7.9 years, respectively.
Figure 3
Figure 3
Explanations for penetrance of XDP in women. A. A homozygous carrier of the XDP haplotype. B. A Bell curve showing the effect of X-chromosome inactivation (XCI) on the penetrance of XDP in heterozygous female XDP-haplotype carriers. Xm – affected X chromosome (i. e., X chromosome containing the XDPhaplotype), Xwt wildtype X chromosomes. The silenced X chromosome is shown in red and the one that is expressed in green. The percentages below the curve are the ratios of cells with silenced affected vs. unaffected X chromosome. White female figures – unaffected heterozygous carriers; light and dark red female figures, mildly or severely affected female XDP patients, respectively. C. A woman with X chromosome monosomy (45, X), harboring only the affected X chromosome in all her cells.

Similar articles

  • X-linked dystonia-parkinsonism: over and above a repeat disorder.
    Pozojevic J, Cruz JN, Westenberger A. Pozojevic J, et al. Med Genet. 2022 Jan 12;33(4):319-324. doi: 10.1515/medgen-2021-2105. eCollection 2021 Dec. Med Genet. 2022. PMID: 38835428 Free PMC article.
  • A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A, Reyes CJ, Saranza G, Dobricic V, Hanssen H, Domingo A, Laabs BH, Schaake S, Pozojevic J, Rakovic A, Grütz K, Begemann K, Walter U, Dressler D, Bauer P, Rolfs A, Münchau A, Kaiser FJ, Ozelius LJ, Jamora RD, Rosales RL, Diesta CCE, Lohmann K, König IR, Brüggemann N, Klein C. Westenberger A, et al. Ann Neurol. 2019 Jun;85(6):812-822. doi: 10.1002/ana.25488. Epub 2019 May 3. Ann Neurol. 2019. PMID: 30973967
  • Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset.
    Trinh J, Lüth T, Schaake S, Laabs BH, Schlüter K, Laβ J, Pozojevic J, Tse R, König I, Jamora RD, Rosales RL, Brüggemann N, Saranza G, Diesta CCE, Kaiser FJ, Depienne C, Pearson CE, Westenberger A, Klein C. Trinh J, et al. Brain. 2023 Mar 1;146(3):1075-1082. doi: 10.1093/brain/awac160. Brain. 2023. PMID: 35481544 Free PMC article.
  • X-Linked Dystonia-Parkinsonism.
    Evidente VGH. Evidente VGH. 2005 Dec 13 [updated 2018 Feb 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2005 Dec 13 [updated 2018 Feb 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301662 Free Books & Documents. Review.
  • X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
    Chin HL, Lin CY, Chou OH. Chin HL, et al. Acta Neurol Belg. 2023 Feb;123(1):45-55. doi: 10.1007/s13760-022-02144-3. Epub 2022 Nov 23. Acta Neurol Belg. 2023. PMID: 36418540 Review.

Cited by

  • Genetic Landscape of Dystonia in Asian Indians.
    Saini A, Singh I, Kumar M, Radhakrishnan DM, Agarwal A, Garg D, Elavarasi A, Singh R, Chouhan V, Sandeep, Gupta A, Vishnu VY, Singh MB, Bhatia R, Garg A, Gupta N, Mir RA, Faruq M, Binukumar BK, Srivastava AK, Rajan R. Saini A, et al. Mov Disord Clin Pract. 2025 May;12(5):594-601. doi: 10.1002/mdc3.14325. Epub 2025 Jan 3. Mov Disord Clin Pract. 2025. PMID: 39749944

References

    1. Lee LV, Rivera C, Teleg RA. et al. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, “Lubag”) Int J Neurosci. 2011;121(Suppl 1):3–11. - PubMed
    1. Lee LV, Kupke KG, Caballar-Gonzaga F. et al. The phenotype of the X-linked dystonia-parkinsonism syndrome: An assessment of 42 cases in the Philippines. Medicine. 70:179–87. - PubMed
    1. Pauly MG, Ruiz López M, Westenberger A. et al. Expanding Data Collection for the MDSGene Database: X-linked dystonia-parkinsonism as use case example. Mov Disord. 2020;35:1933–8. - PubMed
    1. Westenberger A, Reyes CJ, Saranza G. et al. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism. Ann Neurol. 2019;85(6):812–22. - PubMed
    1. Pasco PMD, Ison CV, Muňoz EL. et al. Understanding XDP through imaging, pathology, and genetics. Int J Neurosci. 2010;121:12–7. - PubMed

LinkOut - more resources